drugset / Trial / NCT00687271
A Study of MK-6213 Co-Administered With Atorvastatin in Participants With Hypercholesterolemia (MK-6213-006)
RandomizedFactorialDouble-blindTreatment
Summary
The purpose of this study is to test the safety and effectiveness of MK-6213 as compared to MK-6213/Atorvastatin in participants 18 to 75 years) with high cholesterol.
Timeline
- Start
- 2008-06-14
- Primary completion
- 2009-01-08
- Completion
- 2009-01-08
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Atorvastatin | Small molecule | 20 mg | Oral |
| Subject | MK-6213 | Unknown | 160 mg | Oral |